17.01.2019 • News

Bayer to Cut Over 500 Jobs Near Pittsburgh

Bayer to Cut Over 500 Jobs Near Pittsburgh (c) Bayer
Bayer to Cut Over 500 Jobs Near Pittsburgh (c) Bayer

As it prepares to weed 12,000 jobs out of its pre-Monsanto organization by 2021, Bayer has begun consolidating corporate functions in the US.

In a first step, the US subsidiary of the German group is shutting its base at Robinson, Pennsylvania, near Pittsburgh. The jobs of some 569 employees and 96 independent contractors will be axed over the next two years. Most of the cutbacks will target administrative support positions in fields such as IT, accounting, legal and compliance.

“We will transition the site closing in a thoughtful, orderly manner over a two-year period to provide ample time for employees and operations to transition smoothly and to ensure that we continue to serve our customers and businesses effectively,” Bayer said in a statement.

US reports pointed to the significance of the Pittsburgh area site in Bayer’s  industrial and more recent past. The area was home to the Leverkusen-headquartered group’s erstwhile joint venture with Monsanto, MoBay and with the spinoff of Bayer MaterialScience as Covestro in 2015 it became the North American hub of the plastics maker.

Bayer’s US operations will see additional job cut as the group carves out its animal health business and part of its consumer health franchise and with the  consolidation of its CropScience segment, where 4,100 jobs are threatened by the merger of Bayer and Monsanto agriculture operations.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read